SCHEMBL32669892

SCHEMBL32669892

COc1cc(/C(O)=C(\C#N)C(=O)N(C)Cc2cccc(C)c2O)cc([N+](=O)[O-])c1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 7/20 0.48
COMT P21964 5/20 0.48
EGFR P00533 2/20 0.40
TTR P02766 1/20 0.39
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 2/20 0.38
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
HTT P42858 2/20 0.36
GAA P10253 1/20 0.36
JUN P05412 1/20 0.36
TDP1 Q9NUW8 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
THRB P10828 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669575 0.93 FTO (0.47) FTOCOMTEGFRTTRMAPT
SCHEMBL32670024 0.90 FTO (0.52) FTOCOMTEGFRTTRMAPT
SCHEMBL32669973 0.89 FTO (0.62) FTOCOMTTTRMAPTALDH1A1
SCHEMBL32669884 0.88 FTO (0.49) FTOCOMTEGFRTTRGAA
SCHEMBL32669782 0.88 FTO (0.48) FTOCOMTEGFRTTRMAPT
SCHEMBL32669829 0.88 FTO (0.48) FTOCOMTEGFRTTRMAPT
SCHEMBL32669992 0.88 FTO (0.51) FTOCOMTEGFRTTRMAPT
SCHEMBL32669623 0.87 FTO (0.47) FTOCOMTEGFRTTRMAPT
SCHEMBL32669754 0.87 FTO (0.46) FTOCOMTEGFRTTRMAPT
SCHEMBL32669744 0.87 FTO (0.52) FTOCOMTEGFRTTRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885EGFR 897/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.